Quality Comes First

COUNTRIES

CONTACT US

Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

Read more

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Contact Us

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

Read more

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Follow Us On Linkedin

Relapsed/Refractory CD123 Expressing Hematologic Malignancies

Slider oncology

Relapsed/Refractory CD123 Expressing Hematologic Malignancies (Acute lymphoblastic leukemia, Acute Myeloid Leukemia, Hodgkin lymphoma, Multiple Myeloma)

CD123 is a cell surface target expressed on a wide range of malignancies including blastic plasmacytoid dendritic cell neoplasm (BPDCN), certain myeloproliferative neoplasms (MPNs) including chronic myelomonocytic leukemia (CMML) and myelofibrosis (MF), acute myeloid leukemia (AML) (and potentially enriched in certain AML subsets), myelodysplastic syndrome (MDS), and chronic myeloid leukemia (CML).
CD123 has also been reported on multiple myeloma (MM), acute lymphoid leukemia (ALL), hairy cell leukemia (HCL), Hodgkin’s lymphoma (HL), and certain Non-Hodgkin’s lymphomas (NHL).
In addition, CD123+ cells have been detected in the tumor microenvironment of several solid tumors as well as in certain autoimmune disorders including cutaneous lupus and scleroderma.

CD123 represents a potential target for therapeutic research in a variety of cancers beyond BPDCN, as well as certain autoimmune disorders. Expression of CD123 has also been associated with poor prognosis and clinical outcomes in additional diseases including AML and CMML.

oncology

Follow Us

A.Menarini Industrie Farmaceutiche Riunite S.r.l.

VAT number and registration number in the Company House: 00395270481
Office of the Companies House: Florence
Share Capital: € 150.000.0000 I.V.

 

© 2025 The Menarini Group - All rights reserved

Fraud Warning Disclaimer

Please be aware that certain individuals might approach you by falsely presenting themselves as our employees, affiliates, agents or representatives. Under this false pretense, they might try to gain access to your personal information or to acquire money or other valuables from you by offering fictitious employment opportunities or by claiming that they are contacting you on our behalf. The contacting individual or organisation may, for example, claim that we can guarantee your employment if you pay them a certain amount of money. Such fraudulent offers and claims are usually received via email, the internet, text message, phone, etc. These claims and offers are fraudulent and invalid and you are strongly advised to exercise great caution when you receive such an offer of employment or notice. Be very mindful of such scams.Below we list some of the features such an offer or claim may have:

Below we list some of the features such an offer or claim may have:

• It may propose a phone or instant message program interview and/or money as a precondition for hiring You may be requested to disclose private, sensitive or confidential information

• You may be told that you were contacted in such a manner because it is a matter of urgency

Such an offer or claim will probably be in the form of an email sent from a fake email address or from a free email address and not from an official Menarini Group email address. Please take extra caution while examining such an email address, as the perpetrators may misspell an official Menarini Group email address and use a slightly modified version of an official Menarini Group email address.

Please note that you will never receive a fraudulent employment offer or any other similar claim from us, because we do not provide any recruitment services. Moreover, we will never ask you for money in exchange for employment opportunities or other similar services. Any such offer of employment or any other service in exchange for fees that claims to be from us is deceitful and part of a fraud.

Criminal and/or civil liabilities may arise from such actions and we intend to cooperate with competent law enforcement agencies. Accordingly, we would ask you to immediately get in touch with us upon receiving a suspicious offer or claim and additionally notify the police or other competent authority.

In any case, please disregard any written or oral request related to a job offer or an interview that you believe is or might be fraudulent or suspicious.

Please note that under no circumstances shall Menarini Group be held liable or responsible for any claims, losses, damages, expenses or other inconvenience resulting from or in any way connected to the actions of these imposters.

Fake Job Awareness

Fake job advertisements are increasingly appearing on the internet and social media. Please be aware of employment scams where people or entities misuse Menarini or Stemline's names to post fake job advertisements.

Stemline will only extend an offer with an interview process and will never charge any money for joining our company. All our current job openings are displayed on the Careers section of our Menarini website, accessible here: https://www.menarini.com/en-us/careers/careers-in-oncology

How to protect against a fake job scam:

  • Never pay for anything in response to a job application or offer.
  • If you receive an offer for a job, you did not apply for, it is fake.
  • A job offer without a personal interview or interaction is a scam.
  • Menarini or Stemline never post jobs on Facebook; if you see one, it is a scam.
  • Watch out for badly written emails or emails not coming from an official Menarini or Stemline company domain.
  • Always check the official company Menarini-Stemline website to ensure that the job exists.
  • Listen to your instincts; if you suspect a scam, it probably is.

Menarini Corporate > servicesplatform MENARINI

This webpage contains features designed to interoperate with other tools.

Menarini does not warrant the continued availability of this page or the tools.

By submitting information and/or documentation to menarini through this portal, you grant to menarini the right to freely use such information and/or documentation on a worldwide, perpetual and royalty-free basis in order to evaluate possible business opportunities.